Ketorolac Production Cost Reports

The report provides a detailed analysis essential for establishing a Ketorolac production plant. It encompasses all critical aspects necessary for Ketorolac production, including the cost of Ketorolac production, Ketorolac plant cost, Ketorolac production costs, and the overall Ketorolac production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Ketorolac production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Ketorolac is a nonsteroidal anti-inflammatory drug (NSAID) that is widely used for its strong pain-relieving and anti-inflammatory properties. It is mainly used for the short-term management of moderate to severe pain, especially after surgeries or medical procedures. It finds its application in managing postoperative pain, where it helps reduce the need for opioid medications.

It is administered by injection to provide quick pain relief in hospitals, while oral and ophthalmic forms are used for ongoing treatment. It is often used in the treatment of musculoskeletal pain, dental pain, and injuries related to joints and tissues. Moreover, eye drop formulations of Ketorolac are used to reduce inflammation, redness, and discomfort after eye surgery or in cases of allergic conjunctivitis. It serves as an alternative to opioid painkillers in many clinical settings, which helps manage pain without the risk of dependency.

The market for Ketorolac is primarily driven by its utilisation as an effective and non-opioid option for short-term pain management, which contributes to its demand in the pharmaceutical industry. Its application as a nonsteroidal anti-inflammatory drug (NSAID) in postoperative pain relief significantly boosts its demand in the healthcare and pharmaceutical industries.

Its usage as a painkiller medication in musculoskeletal pain management and in ophthalmic formulations for eye inflammation further contributes to its growing demand in the medical and healthcare sectors. Industrial Ketorolac procurement is influenced by several factors, including the cost and availability of raw materials, adherence to pharmaceutical quality standards, and regulatory requirements. Additionally, advancements in drug formulation technologies, reliable supply chains, sustainable production practices, and global healthcare expansion further impact its demand and procurement trends.

Raw Material for Ketorolac Production

According to the Ketorolac production plant project report, the major raw materials for Ketorolac production include 2-Methylthiopyrrole and N,N-Dimethylbenzamide.

Production Process of Ketorolac

The extensive Ketorolac production cost report consists of the following industrial production process:

1. Production via Benzoylation: The production process of Ketorolac starts with the benzoylation of 2-methylthiopyrrole using N,N-dimethylbenzamide in the presence of phosphorus oxychloride (POCl3) under reflux in dichloromethane, which produces 5-benzoyl-2-methylthiopyrrole. Then, this compound is condensed with spiro-5,7-dioxa-6,6-dimethyloctane-4,8-dione in the presence of sodium hydride (NaH) in dimethylformamide (DMF) to form an intermediate. The obtained product is oxidised using m-chloroperbenzoic acid in dichloromethane to form the corresponding sulfone, which is further treated with methanol and hydrochloric acid to perform methanolysis, which gives 1-(3,3-dimethoxycarbonylpropyl)-2-methanesulfonyl-5-benzoylpyrrole. Further, this intermediate undergoes cyclisation in DMF with sodium hydride to form dimethyl-5-benzoyl-1,2-dihydro-3H-pyrrolopyrrole-1,1-dicarboxylate. Finally, hydrolysis and decarboxylation of this compound using potassium hydroxide in refluxing methanol leads to the production of Ketorolac, the active anti-inflammatory compound, as the final product.

Ketorolac is a nonsteroidal anti-inflammatory compound (NSAID) belonging to the pyrrolizine carboxylic acid class. It appears as an odourless, white to off-white crystalline powder. The compound is slightly soluble in water, freely soluble in methanol, and sparingly soluble in acetone and ethanol. The molecular formula of Ketorolac is C15H13NO3, and its molar mass is 255.27 g/mol. The density of the compound is approximately 1.31 g/cm³. It has a melting point in the range of 161–163 degree Celsius, and the compound tends to decompose before reaching a boiling state. It is stable under normal storage conditions and should be kept in a tightly closed container, protected from moisture and light. The compound should be handled with care, as its accidental ingestion or exposure may cause irritation and systemic effects such as gastrointestinal discomfort and dizziness.